235 related articles for article (PubMed ID: 37878313)
1. Age, Body Mass Index, Tumor Subtype, and Racial and Ethnic Disparities in Breast Cancer Survival.
Lipsyc-Sharf M; Ballman KV; Campbell JD; Muss HB; Perez EA; Shulman LN; Carey LA; Partridge AH; Warner ET
JAMA Netw Open; 2023 Oct; 6(10):e2339584. PubMed ID: 37878313
[TBL] [Abstract][Full Text] [Related]
2. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
[TBL] [Abstract][Full Text] [Related]
3. Response to Treatment, Racial and Ethnic Disparity, and Survival in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy in the US.
Shubeck S; Zhao F; Howard FM; Olopade OI; Huo D
JAMA Netw Open; 2023 Mar; 6(3):e235834. PubMed ID: 36995711
[TBL] [Abstract][Full Text] [Related]
4. Racial and Ethnic Disparities in Locoregional Recurrence Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer: A Post Hoc Analysis of the TAILORx Randomized Clinical Trial.
Kantor O; King TA; Freedman RA; Mayer EL; Chavez-MacGregor M; Korde LA; Sparano JA; Mittendorf EA
JAMA Surg; 2023 Jun; 158(6):583-591. PubMed ID: 37043210
[TBL] [Abstract][Full Text] [Related]
5. Incidence Trends of Breast Cancer Molecular Subtypes by Age and Race/Ethnicity in the US From 2010 to 2016.
Acheampong T; Kehm RD; Terry MB; Argov EL; Tehranifar P
JAMA Netw Open; 2020 Aug; 3(8):e2013226. PubMed ID: 32804214
[TBL] [Abstract][Full Text] [Related]
6. Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer.
Kyalwazi B; Yau C; Campbell MJ; Yoshimatsu TF; Chien AJ; Wallace AM; Forero-Torres A; Pusztai L; Ellis ED; Albain KS; Blaes AH; Haley BB; Boughey JC; Elias AD; Clark AS; Isaacs CJ; Nanda R; Han HS; Yung RL; Tripathy D; Edmiston KK; Viscusi RK; Northfelt DW; Khan QJ; Asare SM; Wilson A; Hirst GL; Lu R; Symmans WF; Yee D; DeMichele AM; van 't Veer LJ; Esserman LJ; Olopade OI
JAMA Netw Open; 2023 Dec; 6(12):e2349646. PubMed ID: 38153734
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic Characteristics and Prognosis of ERBB2-Low Breast Cancer Among Patients in the National Cancer Database.
Peiffer DS; Zhao F; Chen N; Hahn OM; Nanda R; Olopade OI; Huo D; Howard FM
JAMA Oncol; 2023 Apr; 9(4):500-510. PubMed ID: 36821125
[TBL] [Abstract][Full Text] [Related]
8. Racial and Ethnic Disparity in Preoperative Chemosensitivity and Survival in Patients With Early-Stage Breast Cancer.
Roy AM; Patel A; Catalfamo K; Attwood K; Khoury T; Yao S; Gandhi S
JAMA Netw Open; 2023 Nov; 6(11):e2344517. PubMed ID: 37991763
[TBL] [Abstract][Full Text] [Related]
9. Association of Race/Ethnicity and the 21-Gene Recurrence Score With Breast Cancer-Specific Mortality Among US Women.
Hoskins KF; Danciu OC; Ko NY; Calip GS
JAMA Oncol; 2021 Mar; 7(3):370-378. PubMed ID: 33475714
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer-Related Lymphedema.
Montagna G; Zhang J; Sevilimedu V; Charyn J; Abbate K; Gomez EA; Mehrara B; Morrow M; Barrio AV
JAMA Oncol; 2022 Aug; 8(8):1195-1200. PubMed ID: 35679026
[TBL] [Abstract][Full Text] [Related]
11. Association of PIK3CA Mutation With Pathologic Complete Response and Outcome by Hormone Receptor Status and Intrinsic Subtype in Early-Stage ERBB2/HER2-Positive Breast Cancer.
Zagami P; Fernandez-Martinez A; Rashid NU; Hoadley KA; Spears PA; Curigliano G; Perou CM; Carey LA
JAMA Netw Open; 2023 Dec; 6(12):e2348814. PubMed ID: 38117494
[TBL] [Abstract][Full Text] [Related]
12. Differences in Stage of Cancer at Diagnosis, Treatment, and Survival by Race and Ethnicity Among Leading Cancer Types.
Zhang C; Zhang C; Wang Q; Li Z; Lin J; Wang H
JAMA Netw Open; 2020 Apr; 3(4):e202950. PubMed ID: 32267515
[TBL] [Abstract][Full Text] [Related]
13. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States.
Iqbal J; Ginsburg O; Rochon PA; Sun P; Narod SA
JAMA; 2015 Jan; 313(2):165-73. PubMed ID: 25585328
[TBL] [Abstract][Full Text] [Related]
14. The interrelationship between obesity and race in breast cancer prognosis: a prospective cohort study.
Schindler EA; Takita C; Collado-Mesa F; Reis IM; Zhao W; Yang GR; Acosta LG; Hu JJ
BMC Womens Health; 2024 May; 24(1):312. PubMed ID: 38816709
[TBL] [Abstract][Full Text] [Related]
15. Association of Medicaid Expansion With Mortality Disparity by Race and Ethnicity Among Patients With De Novo Stage IV Breast Cancer.
Malinowski C; Lei X; Zhao H; Giordano SH; Chavez-MacGregor M
JAMA Oncol; 2022 Jun; 8(6):863-870. PubMed ID: 35389432
[TBL] [Abstract][Full Text] [Related]
16. Racial and Ethnic Disparities in Survival Among People With Second Primary Cancer in the US.
Sung H; Nisotel L; Sedeta E; Islami F; Jemal A
JAMA Netw Open; 2023 Aug; 6(8):e2327429. PubMed ID: 37540510
[TBL] [Abstract][Full Text] [Related]
17. Survival Outcomes and Patterns of Care for Stage II or III Resected Gastric Cancer by Race and Ethnicity.
Wu SP; Keshavjee SH; Yoon SS; Kwon S
JAMA Netw Open; 2023 Dec; 6(12):e2349026. PubMed ID: 38127346
[TBL] [Abstract][Full Text] [Related]
18. Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trials.
Gupta S; Dai Y; Chen Z; Winestone LE; Teachey DT; Bona K; Aplenc R; Rabin KR; Zweidler-McKay P; Carroll AJ; Heerema NA; Gastier-Foster J; Borowitz MJ; Wood BL; Maloney KW; Mattano LA; Larsen EC; Angiolillo AL; Burke MJ; Salzer WL; Winter SS; Brown PA; Guest EM; Dunsmore KP; Kairalla JA; Winick NJ; Carroll WL; Raetz EA; Hunger SP; Loh ML; Devidas M
Lancet Haematol; 2023 Feb; 10(2):e129-e141. PubMed ID: 36725118
[TBL] [Abstract][Full Text] [Related]
19. Disparities at the Intersection of Race and Ethnicity: Examining Trends and Outcomes in Hispanic Women With Breast Cancer.
Champion CD; Thomas SM; Plichta JK; Parrilla Castellar E; Rosenberger LH; Greenup RA; Hyslop T; Hwang ES; Fayanju OM
JCO Oncol Pract; 2022 May; 18(5):e827-e838. PubMed ID: 33026950
[TBL] [Abstract][Full Text] [Related]
20. Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial.
Albain KS; Gray RJ; Makower DF; Faghih A; Hayes DF; Geyer CE; Dees EC; Goetz MP; Olson JA; Lively T; Badve SS; Saphner TJ; Wagner LI; Whelan TJ; Ellis MJ; Wood WC; Keane MM; Gomez HL; Reddy PS; Goggins TF; Mayer IA; Brufsky AM; Toppmeyer DL; Kaklamani VG; Berenberg JL; Abrams J; Sledge GW; Sparano JA
J Natl Cancer Inst; 2021 Apr; 113(4):390-399. PubMed ID: 32986828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
